Atlas Trials

Second-Line Irinotecan vs. ILF for AGC

Clinical trial NCT00509964 · UNKNOWN

Trial details

NCT number
NCT00509964
Sponsor
Gachon University Gil Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Stomach NeoplasmMetastaticSecond-Line
Start date
2007-05-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.